Sign In
Last checked at 
7 Oct 2013 08:29
Epistem Holdings Plc ("Epistem" or the "Company")
Directors' Shareholdings
Epistem today provides an update regarding the Company's share investment plan, details of which were announced on 13 July 2009.
As a result of the subscription for Partnership Shares and the award of Matching Shares, the executive Directors each increased their beneficial interests in the Company by 228 ordinary shares of 1.5p each. These shares were acquired on 30th July 2013, 30th August 2013 and 27th September 2013 at prices of 583p, 560p and 383p respectively.
Following these transactions, the current beneficial interests of the executive Directors are set out below:
Ordinary Shares %
Matthew Walls 10,600 0.11%
Dr Catherine Booth 984,955 10.17%
Dr Jeffrey Moore 14,280 0.15%
John Rylands 194,853 2.01%
For further details please contact:
Epistem Plc
Matthew Walls, CEO +44 161 606 7258
John Rylands, Finance Director +44 161 606 7244
Peel Hunt LLP
James Steel /Vijay Barathan +44 20 7418 8900
Follow the stocks
